Platypnea-Orthodeoxia Syndrome after Transcatheter Aortic Valve Implantation.
Progressive dyspnea and hypoxaemia in the subacute phase after transcatheter aortic valve implantation (TAVI) are uncommon and warrant immediate assessment of valve and prosthesis leaflet function to exclude thrombosis, as well as investigation for other causes related to the procedure, such as left ventricular dysfunction, pulmonary embolism, and respiratory sepsis. In this case, we report the observation of a patient presenting two weeks after TAVI with arterial hypoxaemia in an upright position, relieved by lying flat, and coupled with an intracardiac shunt detected on echocardiography in the absence of pulmonary hypertension, raising the suspicion of Platypnea-Orthodeoxia Syndrome (POS). Invasive intracardiac haemodynamic assessment showed a significant right-to-left shunt (Qp/Qs = 0.74), which confirmed the diagnosis, with subsequent closure of the intracardiac defect resulting in immediate relief of symptoms and hypoxaemia. To our knowledge, this is the first reported case of an interatrial defect and shunt causing Platypnea-Orthodeoxia Syndrome after transcatheter aortic valve implantation, resolved by percutaneous device closure.
Institut Cardiovasculaire Paris-Sud, Hôpital Privé Jacques Cartier, 91300 Massy, France.
Andrew K
0000-0001-5677-1048
AK
Roy
Institut Cardiovasculaire Paris-Sud, Hôpital Privé Jacques Cartier, 91300 Massy, France.
Jerome
J
Garot
Institut Cardiovasculaire Paris-Sud, Hôpital Privé Jacques Cartier, 91300 Massy, France.
Antoinette
A
Neylon
Institut Cardiovasculaire Paris-Sud, Hôpital Privé Jacques Cartier, 91300 Massy, France.
Marco
0000-0002-9762-9133
M
Spaziano
Institut Cardiovasculaire Paris-Sud, Hôpital Privé Jacques Cartier, 91300 Massy, France.
Fadi J
FJ
Sawaya
Institut Cardiovasculaire Paris-Sud, Hôpital Privé Jacques Cartier, 91300 Massy, France.
Thierry
T
Lefèvre